• Sarepta Therapeutics Appoints Michael Chambers and Kathryn Boor, Ph.D., to Its Board of Directors

    Source: Nasdaq GlobeNewswire / 02 Jun 2022 16:05:00   America/New_York

    N/A
Share on,